Log in | Register

Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care

E. Schaden| P. G. Metnitz| G. Pfanner| S. Heil| T. Pernerstorfer| P. Perger| H. Schoechl| D. Fries| M. Guetl| S. Kozek-Langenecker
Original
Volume 38, Issue 6 / June , 2012

Pages 984 - 990

Abstract

Purpose

Venous thromboembolism (VTE) is a common but often overlooked life-threatening complication of critical illness. The aim of this cross-sectional survey was to assess current practice of thromboprophylaxis as well as adherence to international guidelines.

Methods

After ethics committee approval, all intensive care units in Austrian hospitals treating adult patients were invited to participate in this web-based survey. Anonymized data on each patient treated at the participating intensive care units on Coagulation Day 2010 were collected using an electronic case report form. Risk assessment, choice and monitoring of anticoagulants, means of mechanical prophylaxis, and demographic data were recorded.

Results

Data from 325 critically ill patients were collected. Patients had a median of four risk factors for thrombosis and 6 % suffered from VTE. Of the 325 patients, 80 % received low molecular weight heparins subcutaneously, 10 % received unfractionated heparin intravenously, 1 % received alternative anticoagulants and 9 % received no pharmacological prophylaxis. Mechanical prophylaxis was used in 49 % with a predominant use of graduated compression stockings. In 39 % a combination of pharmacological and mechanical prophylaxis was applied and 5 % received no prophylaxis at all. Overall guideline adherence was 40 % on Coagulation Day 2010.

Conclusion

Current practice of thromboprophylaxis is predominantly based on the administration of low molecular weight heparins prescribed at rather arbitrary doses without a discernible relationship to drug monitoring, thromboembolic risk factors, vasopressor use or fluid balance. The use of mechanical prophylaxis, evaluation of risk scores and overall guideline adherence must be further encouraged by education, training and communication.

Keywords

References

  1. Levi M (2008) Hemostasis and thrombosis in critically ill patients. Semin Thromb Hemost 34:415–416
    • View reference on PubMed
    • View reference on publisher's website
  2. Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ; American College of Chest Physicians (2008) Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):110S–112S
    • View reference on PubMed
    • View reference on publisher's website
  3. Anderson FA Jr, Spencer FA (2003) Risk factors for venous thromboembolism. Circulation 107(23 Suppl 1):I9–16
    • View reference on PubMed
  4. Cushman M (2007) Epidemiology and risk factors for venous thrombosis. Semin Hematol 44:62–69
    • View reference on PubMed
    • View reference on publisher's website
  5. Dörffler-Melly J, de Jonge E, Pont AC, Meijers J, Vroom MB, Büller HR, Levi M (2002) Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors. Lancet 359:849–850
    • View reference on PubMed
    • View reference on publisher's website
  6. Rommers MK, Van der Lely N, Egberts TC, van den Bemt PM (2006) Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study. Crit Care 10:R93
    • View reference on PubMed
    • View reference on publisher's website
  7. Kahn SR (2011) The post thrombotic syndrome. Thromb Res 127(Suppl 3):S89–S92
    • View reference on PubMed
    • View reference on publisher's website
  8. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE) (2007) Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764
    • View reference on PubMed
  9. Crowther MA, Cook DJ (2008) Preventing venous thromboembolism in critically ill patients. Semin Thromb Hemost 34:469–474
    • View reference on PubMed
    • View reference on publisher's website
  10. Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun-Buisson C; French and Canadian ICU Directors Groups (2003) Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care 18:228–237
    • View reference on PubMed
    • View reference on publisher's website
  11. Imberti D, Ageno W (2005) A survey of thromboprophylaxis management in patients with major trauma. Pathophysiol Haemost Thromb 34:249–254
    • View reference on PubMed
    • View reference on publisher's website
  12. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ (2008) Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 4:CD005258
  13. Sachdeva A, Dalton M, Amaragiri SV, Lees T (2010) Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 7:CD001484
    • View reference on PubMed
  14. Fritz E, Them C, Hackl JM (2005) Routine nursing measures for thrombosis prevention in an university hospital. Pflege 18:43–50
    • View reference on PubMed
    • View reference on publisher's website
  15. Eisele R, Kinzl L, Koelsch T (2007) Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. J Bone Joint Surg Am 89:1050–1056
    • View reference on PubMed
    • View reference on publisher's website
  16. Robinson S, Zincuk A, Strøm T, Larsen TB, Rasmussen B, Toft P (2010) Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Crit Care 14:R41
    • View reference on PubMed
    • View reference on publisher's website
  17. Levi M (2010) Adequate thromboprophylaxis in critically ill patients. Crit Care 14:142
    • View reference on PubMed
    • View reference on publisher's website
  18. Bara L, Leizorovicz A, Picolet H, Samama MM (1992) Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group. Thromb Res 65:641–650
    • View reference on PubMed
    • View reference on publisher's website
  19. Leizorovicz A, Bara L, Samama MM, Haugh MC (1993) Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage. Haemostasis 23(Suppl 1):89–98
    • View reference on PubMed
  20. Bara L, Planes A, Samama MM (1999) Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery. Br J Haematol 104:230–240
    • View reference on PubMed
    • View reference on publisher's website
  21. Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M (1994) A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Intern Med 154:49–56
    • View reference on PubMed
    • View reference on publisher's website
  22. Levy JH, Key NS, Azran MS (2010) Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology 113:726–745
    • View reference on PubMed
  23. Schaden E, Schober A, Hacker S, Spiss C, Chiari A, Kozek-Langenecker S (2010) Determination of enoxaparin with rotational thrombelastometry using the prothrombinase-induced clotting time reagent. Blood Coagul Fibrinolysis 21:256–261
    • View reference on PubMed
    • View reference on publisher's website
  24. Cook DJ, Crowther MA, Meade MO, Douketis J (2005) Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care 20:309–313
    • View reference on PubMed
    • View reference on publisher's website
  25. Hilbert P, Teumer P, Stuttmann R (2008) Prevention of thromboembolism in German intensive care units: results of a nationwide survey. Anaesthesist 57:242–250
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement